Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Be...
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
A 46-year-old woman with multiple sclerosis died from progressive multifocal leukoencephalopathy after receiving 37 doses of natalizumab plus interferon beta-1a as part of a clinical trial. At autopsy, there were diffuse macroscopic and microscopic PML lesions. JC virus was identified in cerebrospinal fluid before death and in brain tissue at autop...
Alternative Titles
Full title
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_19808324
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_19808324
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa051782
